Literature DB >> 2836214

Chronic ethanol exposure increases peripheral-type benzodiazepine receptors in brain.

P J Syapin1, R L Alkana.   

Abstract

The effect of chronic ethanol exposure, withdrawal from chronic exposure and short-term ethanol exposure on mouse brain peripheral-type benzodiazepine receptors (PBR) and on PBR from selected peripheral tissues was studied. Male C57BL/6J mice were fed an ethanol-containing liquid diet for 7.75 or 9 days under conditions which produced physical dependence. Control mice received the diet with isocaloric carbohydrates substituted for ethanol. The binding of [3H]Ro5-4864 to PBR was increased in brain membranes, but not heart or kidney membranes, of mice exposed to ethanol for 7.75 days. Scatchard plot analysis indicated that the increase was due to an increase in the apparent number of binding sites and not to a change in receptor affinity. The same results were obtained in ethanol-dependent mice that were withdrawn from the ethanol for 12 h prior to binding determinations. The binding of [3H]PK-11195 to brain PBR was likewise increased in mice made physically dependent on ethanol after 9 days exposure. In contrast to the effects of chronic exposure using the liquid diet, repeated short-term exposure to ethanol following a procedure known to cause functional tolerance (3.6 g/kg i.p. once daily for 4 days) did not significantly affect the binding of [3H]Ro5-4864 to brain when compared to saline-injected and naive control mice. The results are consistent with previous findings and suggest that ethanol exposure causes time-dependent changes in brain PBR that may be linked to the development of physical dependence. However, further studies are necessary to determine whether the increase in brain PBR sites of alcohol-dependent mice is causally related to the development of alcohol dependence.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2836214     DOI: 10.1016/0014-2999(88)90638-3

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

Review 1.  Imaging Biomarkers of the Neuroimmune System among Substance Use Disorders: A Systematic Review.

Authors:  Eric A Woodcock; Ansel T Hillmer; Graeme F Mason; Kelly P Cosgrove
Journal:  Mol Neuropsychiatry       Date:  2019-05-09

2.  Modulation of ethanol withdrawal-induced anxiety-like behavior during later withdrawals by treatment of early withdrawals with benzodiazepine/gamma-aminobutyric acid ligands.

Authors:  Darin J Knapp; David H Overstreet; George R Breese
Journal:  Alcohol Clin Exp Res       Date:  2005-04       Impact factor: 3.455

3.  Genetic analysis of alcohol intake in recombinant inbred and congenic strains derived from A/J and C57BL/6J progenitors.

Authors:  Kathryn Gill; Alan E Boyle
Journal:  Mamm Genome       Date:  2005-05       Impact factor: 2.957

4.  Distinct cell proliferation events during abstinence after alcohol dependence: microglia proliferation precedes neurogenesis.

Authors:  K Nixon; D H Kim; E N Potts; J He; F T Crews
Journal:  Neurobiol Dis       Date:  2008-05-03       Impact factor: 5.996

5.  Microglial activation is not equivalent to neuroinflammation in alcohol-induced neurodegeneration: The importance of microglia phenotype.

Authors:  S Alex Marshall; Justin A McClain; Matthew L Kelso; Deann M Hopkins; James R Pauly; Kimberly Nixon
Journal:  Neurobiol Dis       Date:  2013-01-08       Impact factor: 5.996

Review 6.  Mechanisms of neurodegeneration and regeneration in alcoholism.

Authors:  Fulton T Crews; Kim Nixon
Journal:  Alcohol Alcohol       Date:  2008-10-21       Impact factor: 2.826

7.  Mephedrone in adolescent rats: residual memory impairment and acute but not lasting 5-HT depletion.

Authors:  Craig P Motbey; Emily Karanges; Kong M Li; Shane Wilkinson; Adam R Winstock; John Ramsay; Callum Hicks; Michael D Kendig; Naomi Wyatt; Paul D Callaghan; Iain S McGregor
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

Review 8.  Contribution of TSPO imaging in the understanding of the state of gliosis in substance use disorders.

Authors:  Claire Leroy; Wadad Saba
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-05-27       Impact factor: 9.236

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.